|
|
 |
Registry of Lobbyists - François Laflamme
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 3137 | Active | | | Initial registration date | Last date of any changes | | 26-March-2024 | 26-March-2024 |
|
Lobbyist's Last Name
Laflamme |
Lobbyist's First Name
François |
Middle Initial
|
|
Business Address of Lobbyist
16720, Route Transcanadienne, suite 100 |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 5M3 |
Telephone
14382206808 |
Fax
|
| |
Business or Firm Name for Lobbyist (if applicable)
IQVIA |
Registry of Joint Stock Companies Number
|
Business Address of Lobbyist's Business or Firm
16720, Route Transcanadienne, suite 100 |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 5M3 |
Telephone
14382206808 |
Fax
|
|
| Beneficiary Name |
Beneficiary Type |
|
| IQVIA Inc. |
Parent Company |
View
|
|
|
|
|
Description of Employer's Business:
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries. |
| |
|
|
|
| Description |
|
| Offer IQVIA’s services in its areas of expertise in human health, including technology solutions, advanced analytics and expertise to enable improved management of government data assets and the production of timely and actionable insights that help drive healthcare forward and improve patient outcomes |
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
